In conclusion, the results of this study indicate that maintaining the activity of the neutrophil Irg1/itaconate axis exerts a beneficial effect on both local inflammation control and systemic hematopoietic homeostasis restoration in colitis, suggesting that itaconate may have a promising clinical translational prospect for IBD-like diseases. Here, ACOD1 is linked to inflammatory bowel disease.